ITYS
15 hours ago
Still blown away that BC took all the recipes, wiped out 65k debt and kept 50% of the inventory Medesol original brought in deal.
THATS an ass kicking so obviously Medesol owners got caught doing backdoor crap, like Medesol Health?
SO BC returns 450M common shares (45,000 PFD D) back to treasury
WHO cares if Medesol can still use their own blends, what new partners will trust them?
HUGE SCORE and to go along with the SIO2 and Fire BC owns....UPLIST, OFFERING...its all coming !
I ll be back
17 hours ago
Slow down tiger. Possession???
Johnston's and Williams still have rights and possession of these products
Perhaps you should read the lastest filing before spreading more lies.
Gotta to love the facts versus a poster who can't read Edgar filings:
The license agreement between MedeSol and BC for the SiO2 products, dated August 8, 2022 and amended on October 20, 2023 is superseded by the Accelerated Closing Of Asset Purchase Agreement and Termination Of Consulting Agreement dated August 9, 2024. Bruce Johnston, (CEO of SiO2) retains the 5,000 shares of BC Series D Preferred stock he currently holds, MedeSol will return 20,000 shares of BC Series D Preferred stock, retains all SiO2 inventory held at Dimachem, and MedeSol hereby assigns the referenced SiO2 Intellectual Property to BC. The Parties acknowledge that SiO2 and BC signed an agreement August 13, 2024, Royalty Agreement and Conditional License for Additional (SIO2) Formulations and are currently in negotiations to purchase all remaining SiO2 product lines.
https://www.sec.gov/Archives/edgar/data/1144392/000147793225000635/mgon_1u.htm
I know it's hard for you, but try to keep up. Thanks for playing along, only helps us expose your efforts.
ITYS
1 day ago
One would think the resident basher would love the fact the management took heed to his warnings about the Johnstons', Williams and all the coronacide, medecide, matrix wellness, fabricated white papers, hiring a felon??????? that was all posted daily for months...NOW MGON took all the recipes, took back all the stock, took Winner Medical and wiped out debt off books....so now what is issue???
clowns will be clowns
ITYS
1 day ago
Zero affect to mgon board. Let him spew, when MGON launches the real fire break blends that are already certified then GEVI is obsolete. ALL they have is tri potassium citrate and its too expensive, no ground life as Megola's AF31 is APP based with other char additives and proven. GEVI blend has a EPA safer label that is a volunteer registration, comical, but the Conman can market and sells smoke n mirrors.
AF31,AF21 real deals
I ll be back
2 days ago
Pre-revenue stock plays.
Understood, but despite MGON's "game plan" mostly being laid out, it's seemingly not even attracted many speculative investors. Not like it's unheard of for people to pile into pre-revenue stock plays.
You are correct, when it's a stock tied to Naz or Dow. However, even in those markets, you find REAL companies that fall under a different level of reporting requirements and must maintain a value level that will qualify them to be traded on the exchange. Within these markets you will find the majority of the stocks do trade on "pre-revenue" forecast. OTC is a completely different animal.
95% of OTC stocks are nothing more than a "pipe dream" and are run by mom & pops or scammers that are either set up to rip off investors or who have NO idea how to bring their dream into reality. Additionally, it's not uncommon to find them loaded up with billions in worthless shares.
The key is to find a new start up that has a low share count with an experienced management team. Now add in a team that starts to show a track record of implementing their business plan (assuming it's the correct plan). All the time knowing that it can fall apart.
What was impressive with the recent unfolding was how BC walked away from Jeffery and Simon by getting all the shares back and keeping the rights to the IP. I can assure you, if they had not retained these rights, this stock would have fallen back to the trips.
Until BC can show the market and its shareholders they can land revenues, this stock is nothing more than just another pipe dream IMO. That said, I like the way this dream is lining up or I wouldn't be here.
I ll be back
2 days ago
Pilot trail and connecting the dots.
While the name change and uplisting is MUCH needed, IMO it doesn't have a meaningful impact on the share value short term. That being said, are we deeper into the weeds with Winner then meets the eye?
Patent Application:
On June 25, 2024, the Company’s technology licensor, MedeSol Global, Inc., filed a provisional patent application covering various odor control product formats including Porta Potty deodorization. This filing is included in the existing license agreement, furthering the Company’s broad intellectual property portfolio.
On December 9, 2024:
Winner Medical has completed manufacturing the incontinence diaper prototypes for human wear testing, which is now being initiated.
On January 30, 2025:
Breakthrough Chemistry wishes our esteemed Chinese business partners at Winner Medical Co. a Happy Chinese New Year! Winner Medical Co. will be closed for the holidays, and we will resume our discussions for the live diaper pilot trial after the holidays end on February 12th.
When I hear "pilot trial" with a manufacture, it would tell me that BC is deeper into the weeds than meets the eye. A trial would indicate that Winner is tooling up and confirming if they have any issues with meeting production requirements. It's a test for Winner to take BC product to the next phase.
The last filing noted:
Winner Medical has completed manufacturing the incontinence diaper prototypes for human wear testing, which is now being initiated.
That was back in early December the prototypes were "being initiated", now just five days ago we learn that BC is in talks to ramp up a pilot trail period for producing the adult diapers.
Experience tells me that the odds of seeing production with a $1.1 Billion dollar company is about to unfold, which is a HELL of lot more meaningful than a name change.
Four happened just today alone:
https://otce.finra.org/otce/dailyList?viewType=Symbol%2FName%20Changes
I ll be back
2 days ago
Looks like its panning out very nicely under the new management in JUST the last few months. I know it's hard but try to keep up.
Key DD timeline of events showing management isn't holding back!
With the name changed approval (as noted by Fidelity) the OTCQB is NOW close at hand in order to fund the ramp up with Winner, assuming it is even needed.
Funding for production, IF NEEDED:
On May 7, 2024, the Company filed a Registration Statement on Form 1-A with the Securities and Exchange Commission (“SEC”) with respect to the offering of a total of 400,000,000 shares of Common Stock at $0.025 per share for total gross proceeds of up to $10,000,000 (the “Offering”). The Offering received notice of qualification from the SEC on June 12, 2024. The Company has not yet sold any shares under this Offering.
Patent Application:
On June 25, 2024, the Company’s technology licensor, MedeSol Global, Inc., filed a provisional patent application covering various odor control product formats including Porta Potty deodorization. This filing is included in the existing license agreement, furthering the Company’s broad intellectual property portfolio.
Audited Financials:
On August 12, 2024 the Company “audited” financial statements filed with the Securities and Exchange Commission.
Breakthrough Chemistry name change:
On September 12, 2024, the Company executed an Amendment to its Articles of Incorporation with the Secretary of State of Nevada, changing the name of the Company to Breakthrough Chemistry, Inc., having received Board and Majority Shareholder approval.
Four months for approval by FINRA:
On September 19, 2024, the Company filed a Corporate Action with FINRA for an OTC Voluntary Name and Symbol Change to Breakthrough Chemistry, Inc., which was still pending as of the filing date of this report.
Additional team members:
On November 19, 2024, the Company added Paul Cohen and Darryl Campbell as independent members to its Board of Directors and approved an Audit Committee Charter. They will both join the Audit Committee along with existing board member Mark Suchy. The three Audit Committee members bring many years of business experience and have the required financial acumen required to serve on the Audit Committee.
Uplisting filed:
On November 19, 2024, the Company applied for admission to the OTCQB Venture Market. Admission to OTCQB is contingent on a review by OTC Markets.
On December 9, 2024:
Winner Medical has completed manufacturing the incontinence diaper prototypes for human wear testing, which is now being initiated.
FINRA approval:
On December 31, 2024, Team post on X:
1-SA filed! Confident FINRA is nearing a decision on N&S after addressing multiple corporate inquires. Progress continues on OTCQB uplist.
On January 8, 2025, Fidelity shows the first name change filing with Breakthrough Chemistry.
Link for those trying to get up to speed before this rocket takes off with a Winner update:
https://www.sec.gov/Archives/edgar/data/1144392/000147793224008377/mgon_1sa.htm